The first full results from Synergy Disc’s U.S. Investigational Device Exemption study found stronger rates of improvement and pain scores compared to anterior cervical discectomy and fusion, according to an April 2 news release.
Five things to know:
1. In the IDE trial, the disc for single-level degenerative disc disease, saw an 87.1% composite clinical success rate.
2. In the Synergy Disc group, 91.7% of patients achieved clinically meaningful improvement on the Neck Disability Index at two years compared with 75.2% in the fusion group.
3. Synergy Disc patients had lower mean neck pain scores and lower worst arm pain scores compared to the ACDF group.
4. The Synergy Disc group had higher reported patient satisfaction reported by 84.5% of Synergy Disc patients versus 61.6% of fusion patients.
5. “Artificial disc replacement continues to evolve rapidly, and these IDE results tell a clear story – meaningful reductions in neck and arm pain, better function, and higher patient satisfaction over fusion,” Principal Investigator Todd Lanman, MD, said in the release. “For patients, that is just not a statistic. That is the ability to return to an active, unrestricted life. That is what motion preservation is ultimately about.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
